Halloran Announces Participation in September Industry Events

Wed, Sep 6th 2017

Halloran is pleased to announce that we will be participating in three industry events in the month of September. Thought leaders from Halloran will be speaking on panels, presenting on key trends and meeting with peers to discuss opportunities and challenges facing pharma, biotech, and life sciences. We're excited to attend events on both coasts, bolstering our West Coast presence. The details on the three events Halloran is participating in this month are as follows:

  • GTCbio: CNS Diesease Summit: This event takes place September 11-12 in Boston and  will provide a comprehensive look at the current state of CNS, from research to commercialization. Halloran principal consultant, Iva Toudjarska, will be speaking on a panel titled, “CNS Perspectives from Venture Capital & Public Markets.” The panel will take place on September 12th at 9:20 a.m. EDT. Iva will be joined by Barbara Tate of Dementia Discovery Fund/SV Life Sciences, Kevin Bitterman of Atlas Venture, Kiran Reddy of Clarus Ventures, Chritine Brennan of MRL Ventures Fund, Yaron Werber of Ovid Therapeutics and the panel will be moderated by Piper Jaffray of Equity Research/Emerging Biopharma.

Halloran consultant, Anmol Grover, will be the lead presenter of a poster in collaboration with Locust Walk, titled “Comprehensive analyses of drug development and transactional deal landscape for neurodegenerative disorders.” The presentation will take place on September 11th at 5:15 p.m. EDT during the conference’s networking session. For more information on the CNS Diseases Summit, please visit:

  • GTCbio: Cell and Gene Therapy Summit: This summit takes place September 11-12 in Boston and will bring together academia and industry to showcase several new technologies emerging in the field of cell and gene therapy. Halloran COO, Greg Dombal will be speaking on a panel to discuss funding and regulatory challenges. The panel takes place on the 12th at 11:05 a.m. EDT and he will be joined by Cliff Mintz of Bioinsights, Andrew Collard of Back Bay Life Science Advisors and moderator Peadar Mac Gabhann of Biostór Ireland. For more information on the Cell and Gene Therapy Summit, please visit: https://www.gtcbio.com/conferences/cell-gene-therapy/
  • The MedTech Conference: This conference takes place September 25-27 in San Jose and fosters business development, innovative technology, and networking with policymakers, business executives and industry leaders. Halloran managing director’s Joanna Engelke and Paola Murphy will be in attendance to connect with industry leaders and participate in meaningful conversations with peers. There will be an exclusive, invite-only happy hour hosted by Halloran beginning at 5:30 p.m. on the 26th at Mosaic in downtown San Jose.  To request an invite, contact Stephanie Coite at scoite@hallorancg.com For more information on The MedTech Conference, please visit: https://www.themedtechconference.com/home

We look forward to participating in these events and to sharing our takeaways from each! If you are attending any of these events and would like to connect, please feel free to reach out to us at marketing@hallorancg.com.